Treatment of age-related macular degeneration

被引：3
|
作者：
Bunting, Roland [1 ]
Guymer, Robyn [1 ]
机构：
[1] Royal Victorian Eye & Ear Hosp, Melbourne, Vic, Australia
来源：
AUSTRALIAN PRESCRIBER | 2012年 / 35卷 / 03期
关键词：
anti-vascular endothelial growth factor; bevacizumab; choroidal neovascularisation; ranibizumab; RANIBIZUMAB; METAANALYSIS;
D O I：
10.18773/austprescr.2012.038
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Age-related macular degeneration is a common cause of visual loss. There may be choroidal neovascularisation or geographic atrophy. Evidence is accumulating for the importance of avoidable risk factors in age-related macular degeneration, such as smoking and obesity. Research confirms that there is an important hereditary component to the disease. Anti-vascular endothelial growth factors have improved the outlook for patients suffering from neovascular age-related macular degeneration. Recent work has concentrated on refining the frequency and pattern of delivery of these drugs to the vitreous cavity. There are few treatment options for geographic atrophy.
引用
收藏
页码：90 / 93
页数：4
相关论文
共 50 条
  • [41] Ranibizumab for treatment of choroidal neovascularization secondary to age-related macular degeneration
    Bhatnagar, Pawan
    Spaide, Richard F.
    Takahashi, Beatriz S.
    Peragallo, Jason H.
    Freund, K. Bailey
    Klancnik, James M., Jr.
    Cooney, Michael J.
    Slakter, Jason S.
    Sorenson, John A.
    Yannuzzi, Lawrence A.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (07): : 846 - 850
  • [42] Treatment of Exudative Age-Related Macular Degeneration
    Jo, Nam Chun
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2007, 50 (08): : 731 - 735
  • [43] Neovascular Age-Related Macular Degeneration
    Veritti, Daniele
    Sarao, Valentina
    Lanzetta, Paolo
    OPHTHALMOLOGICA, 2012, 227 : 11 - 20
  • [44] Agents for the prevention and treatment of age-related macular degeneration and macular edema: a literature and patent review
    Supuran, Claudiu T.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2019, 29 (10) : 761 - 767
  • [45] Age-Related Macular Degeneration A Review
    Fleckenstein, Monika
    Schmitz-Valckenberg, Steffen
    Chakravarthy, Usha
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (02): : 147 - 157
  • [46] Treatment of neovascular age-related macular degeneration with Ranibizumab/LucentisTM
    Michels, S
    Rosenfeld, PJ
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2005, 222 (06) : 480 - 484
  • [47] Advancements in the treatment of age-related macular degeneration: a comprehensive review
    Papaioannou, Christos
    POSTGRADUATE MEDICAL JOURNAL, 2024, 100 (1185) : 445 - 450
  • [48] Effects of core vitrectomy in the treatment of age-related macular degeneration
    Schramm, Katharina
    Mueller, Michael
    Koch, Frank H.
    Singh, Pankaj
    Kohnen, Thomas
    Koss, Michael J.
    ACTA OPHTHALMOLOGICA, 2014, 92 (05) : 465 - 472
  • [49] Emerging biological therapies for the treatment of age-related macular degeneration
    Asahi, Masumi G.
    Avaylon, Jaycob
    Wallsh, Josh
    Gallemore, Ron P.
    EXPERT OPINION ON EMERGING DRUGS, 2021, 26 (02) : 193 - 207
  • [50] Investigation of genetic base in the treatment of age-related macular degeneration
    Gourgouli, Kalliopi
    Gourgouli, Ioanna
    Tsaousis, Georgios
    Spai, Sofia
    Niskopoulou, Maria
    Efthimiopoulos, Spiros
    Lamnissou, Klea
    INTERNATIONAL OPHTHALMOLOGY, 2020, 40 (04) : 985 - 997
12345